Truist Securities Reiterates Rating on National Health Investors, Inc. $NHI
Key Points
- Truist Securities now rates National Health Investors, Inc. ($NHI) "buy" with a $81.00 target.
- The Street's average $NHI price target is $84.75 (Buy).
- $NHI last traded around $71.27.
Truist Securities reiterated its rating on National Health Investors, Inc. ($NHI) to a "buy" rating, with a price target of $81.00 in a recent research note.
National Health Investors, Inc. ($NHI) Stock
National Health Investors, Inc. Earnings
National Health Investors, Inc. Dividend
Analysts Set New Price Targets
About National Health Investors, Inc.
National Health Investors, Inc. is a self-managed real estate investment trust specializing in sale-leaseback, joint venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical facility investments. NHI's portfolio consists of independent living facilities, assisted living and memory care communities, entrance-fee retirement communities, senior living campuses, skilled nursing facilities and specialty hospitals. National Health Investors, Inc. was established on October 15th 1991 and was incorporated in 1991 in Maryland and is based in Murfreesboro, Tennessee.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.